March 23, 2020 / 1:30 PM / 18 days ago

BRIEF-Intra-Cellular Therapies Announces Availability Of Caplyta™ For Adult Patients With Schizophrenia

March 23 (Reuters) - Intra-Cellular Therapies Inc:

* INTRA-CELLULAR THERAPIES ANNOUNCES AVAILABILITY OF CAPLYTA™ (LUMATEPERONE) FOR ADULT PATIENTS WITH SCHIZOPHRENIA

* INTRA-CELLULAR THERAPIES INC - ANNOUNCED THAT CAPLYTA (LUMATEPERONE) IS NOW AVAILABLE TO PHARMACIES IN U.S. CAPLYTA IS AN ORAL, ONCE DAILY MEDICINE APPROVED FOR TREATMENT OF SCHIZOPHRENIA IN ADULTS Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below